Synthesis, structure and antimicrobial activity of 6-(propan-2-yl)-3-methyl-morpholine-2,5-dione

Abstract Cyclodepsipeptides are known to exhibit a broad spectrum of biological activities and present a great potential for pharmacological application. A novel didepsipeptide member of the family, 6-(propan-2-yl)-3-methyl-morpholine-2,5-dione, was synthesized and its structure was confirmed by IR, 1 H and 13 C NMR spectral data. The structure and relative stability of the diastereoisomers, tautomers and anionic derivatives of 6-(propan-2-yl)-3-methyl-morpholine-2,5-dione were studied by DFT. Different conditions were considered by calculations in gas phase at the B3LYP/6-311++G ** level and in polar medium utilizing PCM methods at the same level of theory. In all cases the keto forms were found to be more stable and this form should be expected to exist in real systems. Experimental evidence for this statement was found by the IR spectra measured in KBr, polar and nonpolar solvent. The IR spectroscopy was employed to monitor the formation of anion derivative of 6-(propan-2-yl)-3-methyl-morpholine-2,5-dione. The corresponding spectral and structural changes, accompanying the molecule → anion conversion were studied by IR spectra and DFT calculations. The 6-(propan-2-yl)-3-methyl-morpholine-2,5-dione showed antimicrobial activity against four of five tested bacterial strains, being the most effective against Escherichia coli .

[1]  Jacopo Tomasi,et al.  Molecular Interactions in Solution: An Overview of Methods Based on Continuous Distributions of the Solvent , 1994 .

[2]  R. Lemmens‐Gruber,et al.  Cyclodepsipeptides - potential drugs and lead compounds in the drug development process. , 2009, Current medicinal chemistry.

[3]  G. von Samson-Himmelstjerna,et al.  Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle , 2004, Parasitology.

[4]  S. Steinberg,et al.  Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin , 2007, Clinical Cancer Research.

[5]  A. Arcelli,et al.  Synthesis of new chiral 1,4 -morpholin -2,5 -dione derivatives and evaluation as α-glucosidase inhibitors. Part 3 , 2007 .

[6]  T. Adachi,et al.  Bassiatin, a new platelet aggregation inhibitor produced by Beauveria bassiana K-717. , 1995, The Journal of antibiotics.

[7]  Y. Suárez,et al.  Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells. , 2003, Molecular cancer therapeutics.

[8]  P. Läuger.  Kinetic properties of ion carriers and channels , 1980, The Journal of Membrane Biology.

[9]  H. Naganawa,et al.  Metacytofilin, a novel immunomodulator produced by Metarhizium sp. TA2759. , 1992 .

[10]  S. Emanuele,et al.  Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). , 2008, International journal of oncology.

[11]  J. Bueren,et al.  In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells. , 2003, Experimental hematology.

[12]  G. Altreuther,et al.  Field evaluation of the efficacy and safety of emodepside/praziquantel spot–on solution against naturally acquired nematode and cestode infections in domestic cats , 2005, Parasitology Research.

[13]  M. Georgieva,et al.  The computational study on the structural and force field changes, caused by the conversion of dicyanamide into the azanion , 2005 .

[14]  V. Minkin,et al.  Quantum Chemistry of Organic Compounds: Mechanisms of Reactions , 1991 .

[15]  J. Leszczynski,et al.  Ab Initio Study of the Prototropic Tautomerism of Cytosine and Guanine and Their Contribution to Spontaneous Point Mutations , 2003 .

[16]  K. Rinehart,et al.  New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials , 2004, Marine Drugs.

[17]  J. Berg,et al.  Principles Of Bioinorganic Chemistry , 1994 .

[18]  A. Grandi,et al.  Chiral 1,4-morpholin-2,5-dione derivatives as α-glucosidase inhibitors: Part 2 , 2005 .

[19]  B. Wang,et al.  Recent developments in depsipeptide research. , 2002, Current medicinal chemistry.

[20]  L. I. Belen’kii,et al.  The Literature of Heterocyclic Chemistry, Part X, 2005–2007 , 2011 .

[21]  L. Nahar,et al.  Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals , 2007, Methods.

[22]  R. Codd.  Traversing the coordination chemistry and chemical biology of hydroxamic acids , 2008 .

[23]  A. Šmelcerović,et al.  Identification and synthesis of three cyclodidepsipeptides as potential precursors of enniatin B in Fusarium sporotrichioides , 2011 .

[24]  L. Radom,et al.  An evaluation of harmonic vibrational frequency scale factors. , 2007, The journal of physical chemistry. A.

[25]  K. Hasumi,et al.  Lateritin, a new inhibitor of acyl-CoA:cholesterol acyltransferase produced by Gibberella lateritium IFO 7188. , 1993, The Journal of antibiotics.

[26]  J. Leszczynski,et al.  Prototropic Equilibria in 4-Thiouracil: A Combined Spectroscopic and ab Initio SCF-MO Investigation , 1998 .

[27]  J. D. Young,et al.  Ionophore-induced apoptosis: role of DNA fragmentation and calcium fluxes. , 1991, Experimental cell research.

[28]  J. Tsenov,et al.  IR spectra and structure of 1-H-isoindole-1,3(2H)-dione (phthalimide), cis-hexahydro-1-H-isoindole-1,3(2H)-dione (hexahydrophthalimide) and of their nitranions , 1999 .

[29]  K. Senthilkumar,et al.  Quantum chemical studies on tautomerism of barbituric acid in gas phase and in solution , 2002, J. Comput. Aided Mol. Des..

[30]  M. Ford,et al.  An investigation of the ionophoric characteristics of destruxin A. , 2002, Archives of biochemistry and biophysics.

[31]  R. Lemmens‐Gruber,et al.  Beauvericin-induced channels in ventricular myocytes and liposomes. , 2003, Biochimica et biophysica acta.

[32]  D. Lepage,et al.  Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma , 2008, British Journal of Cancer.

[33]  M. M. Shemyakin,et al.  Cyclol formation in peptide system tautomerism of N-(α-hydroxyacl)-amides , 1962 .

[34]  A. Šmelcerović,et al.  Stimulatory effect on rat thymocytes proliferation and antimicrobial activity of two 6-(propan-2-yl)-4-methyl-morpholine-2,5-diones. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[35]  R. Lemmens‐Gruber,et al.  Investigation of the electrophysiological properties of enniatins. , 2004, Archives of biochemistry and biophysics.

[36]  M. Frisch,et al.  Ab Initio Calculation of Vibrational Absorption and Circular Dichroism Spectra Using Density Functional Force Fields , 1994 .

[37]  F. Sarabia,et al.  Chemistry and biology of cyclic depsipeptides of medicinal and biological interest. , 2004, Current medicinal chemistry.

[38]  A. Grandi,et al.  Chiral 1,4-Morpholine-2,5-diones. Synthesis and Evaluation as Glucosidase Inhibitors , 2004 .

[39]  Alan R. Katritzky,et al.  Prototropic Tautomerism of Heterocycles: Heteroaromatic Tautomerism—General Overview and Methodology , 2000 .